.Pharmacolibrary.Drugs.ATC.B.B01AC10 .Pharmacolibrary.Drugs.ATC.B.B01AC10| name: | Indobufen | |
| ATC code: | B01AC10 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 200 | mg |
| volume of distribution: | 14 | L |
| clearance: | 11 | L/h |
| other parameters in model implementation | ||
Indobufen is a non-steroidal anti-inflammatory drug (NSAID) with antiplatelet properties, primarily used for the prevention of thromboembolic disorders such as in patients with coronary artery disease and after vascular surgery. It acts as a reversible inhibitor of platelet cyclooxygenase and is approved and used in some countries, particularly in Europe, though it is not universally available worldwide.
Pharmacokinetic parameters based on studies in healthy adult volunteers (both male and female), typically after single oral doses.